Antecedentes da definição do design do sistema de controle gerencial: evidências empíricas nas empresas brasileiras by Fábio Frezatti, Emanuel Junqueira, Diógenes de Souza Bido, Artur Roberto do Nascimento, Tânia Regina Sordi Relvas

“…Dentro do universo do controle gerencial de uma organização, existem vários artefatos, que são implementados com o objetivo de proporcionar aos gestores apoio para o processo decisório, além de coordenação e de influência sobre os colaboradores da empresa (ANTHONY; GOVINDARAJAN, 2002; HANSEN; MOURITSEN, 2007). Entre os vários artefatos existentes, o planejamento estratégico, o orçamento, o orçamento de capital, a análise de lucratividade rolling forecast e as opções reais são exemplos de artefatos citados na literatura como relevantes para o processo de planejamento e controle. …”
Get full text

The circumstances of a Tannenberg notice appearing in the Bychowiec - chronicle by Edvardas Gudavičius

“…Jetzt ist es möglich, über sein Verhältnis auch zu dieser Erzählung zu sprechen. Es gibt in manchen Abschriften der kurzen Redaktion der litauischen Chroniken eine Eintragung über die Tannenbergschlacht, berichtend über den polnischen König Jagiello und den litauischen Großfürsten Witold. …”
Get full text

Development and Validation of a Cost-Effective Machine Learning Model for Screening Potential Rheumatoid Arthritis in Primary Healthcare Clinics by Wu W, Hu X, Yan L, Li Z, Li B, Chen X, Lin Z, Zeng H, Li C, Mo Y, Wu Y, Wang Q

“…Wenqi Wu,1,2,* Xiaohao Hu,1,2,* Linyang Yan,3,* Zhiyin Li,4 Bo Li,5 Xinpeng Chen,6 Zexun Lin,7 Huiqiong Zeng,8 Chun Li,9 Yingqian Mo,10 Yalin Wu,3 Qingwen Wang1,2 1Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, Shenzhen, People’s Republic of China; 2Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen, People’s Republic of China; 3Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, 518036, People’s Republic of China; 4Department of Information Systems, City University of Hong Kong, Hong Kong, People’s Republic of China; 5Department of Rheumatology and Immunology, People’s Hospital of Longhua District, Shenzhen, People’s Republic of China; 6Department of Rheumatology and Immunology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, People’s Republic of China; 7Shenzhen Nanshan Medical Group HQ Taohuayuan Community Health Service Center, Shenzhen, People’s Republic of China; 8Traditional Chinese Medicine Department of Rheumatism, Women & Children Health Institute, Shenzhen, People’s Republic of China; 9Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, People’s Republic of China; 10Department of Rheumatology and Immunology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yalin Wu; Qingwen Wang, Email yalinwu@jj.ac.kr; wangqingwen@pkuszh.comObjective: In primary healthcare, diagnosing rheumatoid arthritis (RA) is challenging due to a general lack of in-depth knowledge of RA by general practitioners (GPs) and the lack of effective tools, leading to high rates of missed diagnosis. …”
Get full text

Analysis of the Rights and Obligations of Stakeholders in China’s National Park Concession System by Le ZHONG, Zhicong ZHAO

“…The research’s specific foci include the Three Rivers Source National Park, Giant Panda National Park, Northeast Tiger and Leopard National Park, Hainan Tropical Rainforest National Park and Wuyi Mountain National Park, as well as the pilot national parks including Qianjiangyuan, Shennongjia, Nanshan, Qilian Mountain and Pudacuo. Guided by the tenets of stakeholder analysis, the research comprehensively identifies the stakeholder composition in national park concessions from three distinct vantage points: “ought to be” (ideal state), “is” (current state), and “enabled to be” (strategies for realization). …”
Get full text

Contextual Vulnerability Should Guide Fair Subject Selection in Xenotransplantation Clinical Trials by Gianna Strand

“…“Avoiding Exploitation in Phase I Clinical Trials: More Than (Un)Just Compensation,” Journal of Law, Medicine & Ethics 46, no. 1 (2018): 52-63.; Jansen, L.A. “A Closer Look at the Bad Deal Trial: Beyond Clinical Equipoise,” Hastings Center Report 35, no. 5 (2005): 29-36. …”
Get full text